BCM
ABBV icon

Brookstone Capital Management’s AbbVie ABBV Stock Holding History

Brookstone Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$135K – 768
2021
Q4 		$135K Buy
+1,000
New +$118K ﹤0.01% 725

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Brookstone Capital Management's ABBV Position: Q2 2026 in Review

Brookstone Capital Management increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $452K and bringing the position to 91,033 shares worth $22.9M. The position accounts for 0.23% of the portfolio, ranked #119.

Brookstone Capital Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 2,813 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brookstone Capital Management held 91,033 shares of AbbVie worth $22.9M as of Q2 2026.
  • Brookstone Capital Management bought 2,099 AbbVie shares in Q2 2026, an estimated $452K.
  • AbbVie made up 0.23% of Brookstone Capital Management's portfolio in Q2 2026, its #119 holding.
  • Brookstone Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 2,813 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.